Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma von Dimopoulos, M A, Chen, C, Spencer, A, Niesvizky, R, Attal, M, Stadtmauer, E A, Petrucci, M T, Yu, Z, Olesnyckyj, M, Zeldis, J B, Knight, R D, Weber, D M

Volltext

Recent clinical studies of the immunomodulatory drug (IMiD ) lenalidomide von BARTLETT, J. B, TOZER, A, STIRLING, D, ZELDIS, J. B

Volltext

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease von Vasiliauskas, Eric A., Kam, Lori Y., Abreu-Martin, Maria T., Hassard, Philip V., Papadakis, Kostas A., Yang, Huiying, Zeldis, Jerome B., Targan, Stephan R.

Volltext

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast von Gottlieb, A. B., Strober, B., Krueger, J. G., Rohane, P., Zeldis, J. B., Hu, C. C., Kipnis, C.

Volltext

Thalidomide as a novel therapeutic agent: new uses for an old product von Teo, Steve K., Stirling, David I., Zeldis, Jerome B.

Volltext

A randomized, double‐blind, placebo‐controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease von MANSFIELD, J. C., PARKES, M., HAWTHORNE, A. B., FORBES, A., PROBERT, C. S. J., PEROWNE, R.C., COOPER, A., ZELDIS, J. B., MANNING, D. C., HAWKEY, C. J.

Volltext

Efficacy of Lenalidomide in Myelodysplastic Syndromes von List, Alan, Kurtin, Sandy, Roe, Denise J, Buresh, Andrew, Mahadevan, Daruka, Fuchs, Deborah, Rimsza, Lisa, Heaton, Ruth, Knight, Robert, Zeldis, Jerome B

Volltext

Thalidomide in the treatment of leprosy von Teo, Steve K., Resztak, Ken E., Scheffler, Michael A., Kook, Karin A., Zeldis, Jerry B., Stirling, David I., Thomas, Steve D.

Volltext

Hepatitis C Virus Is Detected in a Monocyte/Macrophage Subpopulation of Peripheral Blood Mononuclear Cells of Infected Patients von Bouffard, P., Hayashi, P. H., Acevedo, R., Levy, N., Zeldis, J. B.

Volltext

S.T.E.P.S. ™: A comprehensive program for controlling and monitoring access to thalidomide von Zeldis, Jerome B., Williams, Bruce A., Thomas, Steve D., Elsayed, Marc E.

Volltext

Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide von PALUMBO, A., RUS, C., ZELDIS, J. B., RODEGHIERO, F., BOCCADORO, M.

Volltext

Thalidomide and Its Analogues Inhibit Lipopolysaccharide-mediated Induction of Cyclooxygenase-2 von FUJITA, Junya, MESTRE, Juan R, ZELDIS, Jerome B, SUBBARAMAIAH, Kotha, DANNENBERG, Andrew J

Volltext

Thalidomide in the treatment of patients with hepatocellular carcinoma: A phase II trial von PATT, Yehuda Z, HASSAN, Manal M, LOZANO, Richard D, NOOKA, Ajay K, SCHNIRER, Isaac I, ZELDIS, Jerome B, ABBRUZZESE, James L, BROWN, Thomas D

Volltext

Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL) von Chanan-Khan, Asher, Miller, Kena C., Takeshita, Kenichi, Koryzna, Alexandra, Donohue, Kathleen, Bernstein, Zale P., Mohr, Alice, Klippenstein, Donald, Wallace, Paul, Zeldis, Jerome B., Berger, Christine, Czuczman, Myron S.

Volltext

Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age von Mileshkin, Linda, Biagi, James J., Mitchell, Paul, Underhill, Craig, Grigg, Andrew, Bell, Richard, McKendrick, Joe, Briggs, Peter, Seymour, John F., Lillie, Kate, Smith, Jennifer G., Zeldis, Jerome B., Prince, H. Miles

Volltext

Kidney dysfunction during lenalidomide treatment for AL amyloidosis von SPECTER, Richard, SANCHORAWALA, Vaishali, SELDIN, David C, SHELTON, Anthony, FENNESSEY, Salli, F'INN, Kathleen T, ZELDIS, Jerome B, DEMBERI, Laura M

Volltext

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma von HAROUSSEAU, Jean-Luc, DIMOPOULOS, Meletios A, KNIGHT, Robert D, WEBER, Donna M, WANG, Michael, CORSO, Alessandro, CHEN, Christine, ATTAL, Michel, SPENCER, Andrew, ZHINUAN YU, OLESNYCKYJ, Marta, ZELDIS, Jerome B

Volltext

Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial von Sanchorawala, Vaishali, Patel, Jaymin M, Sloan, J Mark, Shelton, Anthony C, Zeldis, Jerome B, Seldin, David C

Volltext

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma von Dimopoulos, Meletios, Spencer, Andrew, Attal, Michael, Prince, H. Miles, Harousseau, Jean-Luc, Dmoszynska, Anna, Miguel, Jesus San, Hellmann, Andrzej, Facon, Thierry, Foà, Robin, Corso, Alessandro, Masliak, Zvenyslava, Olesnyckyj, Marta, Yu, Zhinuan, Patin, John, Zeldis, Jerome B, Knight, Robert D

Volltext

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study von Polizzotto, Mark N, Uldrick, Thomas S, Wyvill, Kathleen M, Aleman, Karen, Peer, Cody J, Bevans, Margaret, Sereti, Irini, Maldarelli, Frank, Whitby, Denise, Marshall, Vickie, Goncalves, Priscila H, Khetani, Vikram, Figg, William D, Steinberg, Seth M, Zeldis, Jerome B, Yarchoan, Robert

Volltext